We, at PROMEPLA, excel in producing biopharmaceuticals for our customers using innovative approaches while maintaining the highest safety standard. We are a full-service partner with expertise in the design, development and manufacture of clinical drugs and therapeutics. At PROMEPLA, we understand our partners need for safe, reliable and efficient drug development and manufacturing services. We use innovative and time-effective approaches in clinical drug design and lead identification, including disease modeling and drug repurposing. We also possess cutting-edge novel facilities for the production of virus-based therapeutics. Promepla: Your best partner for aseptic single-use connections As a part of our fully integrated services, we are capable of scaling up the drug development process from the bench to cGMP manufacturing and can implement local production facilities. With our process design expertise, we can provide manufacturing processes that are truly flexible and reproducible to accelerate the journey of a drug to the market. We specialize in single-use and continuous manufacturing technologies, allowing us to deal with the challenges encountered during scale-up processes and technology transfer. We also possess highly specialized technologies for aseptic fill-finish of liquid and lyophilized biologics. We are capable of working with a variety of biopharmaceuticals, including vaccines, blood, blood components, blood plasma, allergenics, somatic cells, and gene therapies. We have partners in Switzerland and the United States and are looking forward to expanding our operations and partnering with new clients across Europe. Currently, we are involved in the production of a wide variety of therapeutics, including recombinant proteins, in the realm of neuroscience, hematology, genetic disorders, immunology, oncology, gastroenterology, and ophthalmology. We also possess the knowledge and expertise to safely produce gene and cell therapies, including viral vectors, cancer-selective gene therapies, and somatic cells for immunotherapy and hematotherapy. We provide start to finish production services and use innovative approaches in the entire drug development process, from concept to commercialization. We are dedicated to meeting the highest quality and safety standards to ensure that therapeutics are available to those who are in need, and we do so in a time and cost-effective manner. Contact us today to learn more.
BIOPHARM SOLUTIONS
Latest news
November 5, 2024
Component Catalog
